This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. Its structure, featuring both a trifluoromethyl group and a piperazine moiety, makes it valuable in the development of compounds targeting central nervous system disorders, such as antipsychotics and antidepressants. Additionally, it is explored in the design of ligands for receptor binding studies, particularly in the modulation of serotonin and dopamine receptors. Its unique chemical properties also contribute to its use in the development of novel therapeutic agents with improved efficacy and selectivity.